BIOMARIN PHARMACEUTICAL INC (1BMRN.MI) Stock Cash Flow
BIT:1BMRN - Euronext Milan - US09061G1013 - Common Stock - Currency: EUR
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 523.88M | 426.86M | 167.65M | 141.60M | -64.10M | |||
| Depreciation Amortization | 91.14M | 96.43M | 104.39M | 102.00M | 108.00M | |||
| Income Taxes - Deferred | 84.24M | 56.10M | -44.98M | -52.10M | -15.60M | |||
| Change In Working Capital | -201.47M | -216.40M | -336.54M | -96.40M | 66.00M | |||
| Interest Paid | 8.94M | 10.36M | 10.30M | 10.30M | 10.40M | |||
| Taxes Paid | 65.36M | 57.27M | 73.31M | 54.40M | 18.20M | |||
| Other non cash items | 202.47M | 209.86M | 268.75M | 80.80M | 210.20M | |||
| OPERATING CASH FLOW | 700.26M | 572.84M | 159.26M | 175.90M | 304.50M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -80.08M | -97.42M | -107.61M | -131.50M | -119.20M | |||
| Other Investing Activity | 202.57M | 233.91M | -3.63M | 111.50M | -247.10M | |||
| INVESTING CASH FLOW | 122.49M | 136.49M | -111.24M | -20.00M | -366.30M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | -498.16M | -2.29M | -2.60M | -3.00M | |||
| Stock Issued/Repurchased | 42.08M | 49.28M | 69.35M | 69.30M | 49.20M | |||
| Other Financing Activity | -66.39M | -77.56M | -85.79M | -85.40M | -46.20M | |||
| FINANCING CASH FLOW | -522.43M | -526.45M | -18.73M | -18.70M | 0.00 | |||
| Exchange Rate Effect | 1.49M | 4.83M | 1.31M | 0.00 | -100.00K | |||
| CHANGE IN CASH | 301.81M | 187.72M | 30.60M | 137.20M | -61.90M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 700.26M | 572.84M | 159.26M | 175.90M | 304.50M | |||
| Capital Expenditure | -80.08M | -97.42M | -107.61M | -131.50M | -119.20M | |||
| FREE CASH FLOW | 620.18M | 475.42M | 51.65M | 44.40M | 185.30M | |||
All data in USD